Thromb Haemost 1967; 18(03/04): 375-382
DOI: 10.1055/s-0038-1655045
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Activation of Serum Thrombotic Accelerator (STA) by Digitonin and Saponin

R. M Howell*
1   Department of Morbid Anatomy, The Royal Free Hospital School of Medicine, London, W. C. 1
,
G. B. D Scott
1   Department of Morbid Anatomy, The Royal Free Hospital School of Medicine, London, W. C. 1
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
24. Juli 2018 (online)

Summary

The steroid saponins digitonin and saponin white, compounds effective in disrupting membrane lipid-protein, have been shown to activate STA precursor.

Ultracentrifuge studies showed a radical alteration in the floatation behaviour of the precursor complex on activation by digitonin, indicating an increase in its molecular size.

Gel-filtration studies, on the other hand, revealed that activation by digitonin was reversible, since passage down a Sephadex G-200 column not only removed digitonin but abolished all activity, the latter being fully restored by the further addition of digitonin. Furthermore, since the elution positions of inactive precursor and deactivated STA were identical, this de-activation was accompanied by the return of the complex to its original size. The failure of cardiac glycosides, other than digitonin, to activate the precursor may be due to their being more hydrophobic and suggests that hypercoagulability leading to possible thrombosis does not arise from their therapeutic use.

* Present address: Department of Nutrition, Queen Elizabeth College, London, W. 8.


 
  • References

  • 1 Wessler S. Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J. clin. Invest 34: 647 1955;
  • 2 Howell R. M, Scott G. B. D. The role of lipoproteins in the production of hypercoagulability: anew concept. Brit. J. exp. Path 45: 618 1964;
  • 3 Howell R. M, Scott G. B. D. The isolation and partial characterisation of serum thrombotic accelerator (STA). Brit. J. exp. Path 47: 177 1966;
  • 4 Reimer S. M, Wessler S, Deykin D. Serum thrombotic accelerator (STA) activity: its relation to the first phase of clotting. Proc. Soc. exp. Biol. (N. Y) 105: 438 1960;
  • 5 Davson H. Growth of the concept of the paucimolecular membrane. Circulation 26: 1022 1962;
  • 6 Rideal E, Taylor F. H. On haemolysis by anionic detergents. Proc. Roy. Soc. B 146: 225 1957;
  • 7 Howell R. M, Cook M. A, Scott G. B. D. Chemical analysis of proteins low in aromatic amino acids. Nature (Lond) 204: 1088 1964;
  • 8 Kohn J. Small-scale membrane filter electrophoresis and immunoelectrophoresis. Clin, chim. Acta 03: 450 1958;
  • 9 Ribeiro L. P, McDonald H. J. Electrophoresis of lipoproteins using pre-stained serum. J. Chromatog 10: 443 1963;
  • 10 Hanel H. K, Dam H. Determination of small amounts of total cholesterol by the Tschugaeff reaction with a note on the determination of lathosterol. Acta chem. scand 09: 677 1955;
  • 11 Marinetti G. V. Chromatographic separation, identification and analysis of phospatides. J. Lip. Res 03: 1 1962;
  • 12 Donaldson V. H. O, Ratnoff D. Hageman factor: alterations in physical properties during activation. Science 150: 754 1965;
  • 13 Ratnoff O. D, Crum J. D. Activation of Hageman factor by solutions of ellagic acid. J. Lab. clin. Med 05: 359 1964;
  • 14 Connor W. E, Hoak J. C, Warner E. D. Massive thrombosis produced by fatty acid infusion. J. clin. Invest 42: 860 1963;
  • 15 Botti R. E, Ratnoff O. D. The clot promoting effect of soaps of long-chain saturated fatty acids. J. clin. Invest 42: 1569 1963;
  • 16 Cathcart R. T, Blood D. W. Effect of digitalis on the clotting of the blood in normal subjects and in patients with congestive heart-failure. Circulation 01: 1176 1950;
  • 17 Richardson T, Tappel A. L, Smith L. M, Houle C. R. Polyunsaturated fatty acids in mitochondria. J. Lip. Res 03: 344 1962;